You have 9 free searches left this month | for more free features.

ganetespib

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Worldwide (Ganetespib, Niraparib, Carboplatin)

Unknown status
  • Ovarian Cancer
  • +2 more
  • Ganetespib
  • +4 more
  • Innsbruck, Austria
  • +12 more
Jan 26, 2021

Advanced Lung Cancer Trial in United States (Ganetespib (STA-9090) and crizotinib)

Completed
  • Advanced Lung Cancer
  • Ganetespib (STA-9090) and crizotinib
  • Basking Ridge, New Jersey
  • +4 more
Dec 28, 2020

Lung Cancer - Malignant Pleural Mesothelioma Trial in London (Ganetespib)

Completed
  • Lung Cancer - Malignant Pleural Mesothelioma
  • Ganetespib
  • London, United Kingdom
    UCL Cancer Trials Centre
Nov 8, 2019

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2019

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (Ganetespib, Paclitaxel)

Terminated
  • Epithelial Ovarian Cancer
  • +2 more
  • Innsbruck, Austria
  • +9 more
Jun 25, 2019

Malignant Peripheral Nerve Sheath Tumors (MPNST), Sarcoma Trial in United States (ganetespib, Sirolimus)

Completed
  • Malignant Peripheral Nerve Sheath Tumors (MPNST)
  • Sarcoma
  • Santa Monica, California
  • +6 more
May 1, 2019

Breast Cancer Trial in Boston, Concord, Chapel Hill (Fulvestrant, Ganetespib)

Completed
  • Breast Cancer
  • Boston, Massachusetts
  • +4 more
Dec 10, 2018

Ocular Melanoma Trial in Boston (STA-9090)

Completed
  • Ocular Melanoma
  • Boston, Massachusetts
  • +2 more
Oct 16, 2018

Small Cell Lung Cancer Trial in Boston (STA-9090)

Completed
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Apr 12, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in New York (ganetespib, paclitaxel, trastuzumab)

Completed
  • HER2-positive Breast Cancer
  • +6 more
  • ganetespib
  • +3 more
  • New York, New York
  • +1 more
Jun 13, 2018

Cancer, Small Cell Lung Cancer Trial in Washington (Ganetespib, Doxorubicin)

Terminated
  • Cancer
  • Small Cell Lung Cancer
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Mar 22, 2018

Tumors Trial run by the NCI (Ziv-Aflibercept, Ganetespib)

Terminated
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2018

Esophagogastric Cancer Trial in Boston (STA-9090)

Completed
  • Esophagogastric Cancer
  • Boston, Massachusetts
  • +2 more
Jul 31, 2020

Melanoma Trial in Boston (STA-9090)

Terminated
  • Melanoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 1, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma, Stage I Oral Cavity Squamous Cell

Terminated
  • Stage I Hypopharyngeal Squamous Cell Carcinoma
  • +15 more
  • Ganetespib
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jul 22, 2016

Breast Cancer Trial (Ganetespib, Paclitaxel, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Ganetespib
  • +3 more
  • (no location specified)
May 26, 2016

Rectal Cancer Trial in Atlanta (capecitabine + ganetespib)

Completed
  • Rectal Cancer
  • capecitabine + ganetespib
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Feb 19, 2016

Gastrointestinal Stromal Tumor Trial in United States (Ganetespib)

Completed
  • Gastrointestinal Stromal Tumor
  • Ganetespib
  • Los Angeles, California
  • +3 more
Feb 11, 2016

Multiple Myeloma Trial in United States (Ganetespib, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Ganetespib
  • +2 more
  • Denver, Colorado
  • +7 more
Oct 8, 2015

Breast Cancer, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer Trial in Worldwide (ganetespib)

Completed
  • Breast Cancer
  • +3 more
  • ganetespib
  • Birmingham, Alabama
  • +24 more
Nov 4, 2015

Non-Small-Cell Lung Adenocarcinoma, NSCLC Stage IIIB, NSCLC Stage IV Trial in Worldwide (Docetaxel, Ganetespib)

Terminated
  • Non-Small-Cell Lung Adenocarcinoma
  • +3 more
  • Flagstaff, Arizona
  • +267 more
May 26, 2016

NSCLC Stage IIIB, NSCLC Stage IV, NSCLC Metastatic Trial in Worldwide (Docetaxel, Combination of ganetespib and docetaxel)

Terminated
  • Non-small Cell Lung Cancer Stage IIIB
  • +2 more
  • Docetaxel
  • Combination of ganetespib and docetaxel
  • Tucson, Arizona
  • +52 more
Nov 4, 2015